Table 1.
Cell/Animal | Class I PI3K Subunits | Role in Asthma | References |
---|---|---|---|
Mice | p110δ | AHR | 25, 33 |
p110δ | Inflammation | 35 | |
p110γ | Inflammation | 36 | |
p110γ | Remodeling | 36 | |
Airway smooth muscle | p110δ, p110γ | Contraction | 37–42 |
p110α, p110β, p110δ | Proliferation | 18 | |
p110α, p110δ | Gene Expression | 42 | |
p110γ | β-2 Adrenergic Receptor resensitization | 43 | |
p110δ | IL-6 secretion | 44 | |
p110α, p110β, p110δ | VEGF expression | 45 | |
p110α, p110β, p110δ | CXCL-8 expression | 46 | |
p110α, p110β, p110δ | MMP-1 secretion | 47 | |
p110α, p110β, p110δ | Proliferation | 48–52 | |
Airway epithelial cells | p110α, p110β, p110δ | IP-10 secretion | 59 |
p110α, p110β, p110δ | Nitric oxide signaling | 59, 60 | |
p110α, p110β, p110δ | Mucus secretion | 62 | |
T cells | p110δ, p110γ | Th2 differentiation | 27, 63–66 |
B cells | p110α, p110β, p110δ, p110γ | IgE class switching | 67, 68 |
Mast cells | p110δ | Degranulation | 69 |
p110γ | Cytokine release | 70 | |
Eosinophils | p110γ | Chemotaxis | 71, 72 |
p110γ | Mediator release | 73 | |
Neutrophils | p110δ, p110γ | Migration | 75 |
p110α, p110β, p110δ, p110γ | Degranulation | 73 |
Definition of abbreviations: AHR, airway hyperresponsiveness; CXCL-8, C-X-C motif chemokine ligand 8; IP-10, IFN-γ–induced protein 10; MMP-1, matrix metallopeptidase 1; P110α, phosphatidylinositol 3-kinase catalytic subunit α isoform; P110β, phosphatidylinositol 3-kinase catalytic subunit β isoform; P110δ, phosphatidylinositol 3-kinase catalytic subunit δ isoform; P110γ, phosphatidylinositol 3-kinase catalytic subunit γ isoform; PI3K, phosphoinositide 3-kinase; Th2, T-helper cell type 2; VEGF, vascular endothelial growth factor.